Ismael Escobar Rodríguez

ORCID: 0000-0003-4188-7624
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Pharmaceutical Practices and Patient Outcomes
  • HIV/AIDS Research and Interventions
  • HIV/AIDS drug development and treatment
  • Safe Handling of Antineoplastic Drugs
  • Medication Adherence and Compliance
  • Pneumocystis jirovecii pneumonia detection and treatment
  • Pharmaceutical studies and practices
  • Diet, Metabolism, and Disease
  • COVID-19 Clinical Research Studies
  • HIV Research and Treatment
  • Hepatitis C virus research
  • Digestive system and related health
  • Long-Term Effects of COVID-19
  • Helicobacter pylori-related gastroenterology studies
  • HIV-related health complications and treatments
  • Pharmacy and Medical Practices
  • Patient Safety and Medication Errors
  • Liver Disease Diagnosis and Treatment
  • Analytical Methods in Pharmaceuticals
  • Forensic Toxicology and Drug Analysis
  • Hepatitis B Virus Studies
  • Respiratory Support and Mechanisms
  • Antibiotic Use and Resistance
  • Dermatological and COVID-19 studies
  • Intramuscular injections and effects

Hospital Universitario Infanta Leonor
2013-2024

Infant
2022

Universidad San Pablo CEU
2022

Universidad San Pablo
2022

Colegio Metodista de Costa Rica
2022

Universidad de la República de Uruguay
2019

Hospital de Clínicas
2019

Hospital Universitario de Gran Canaria Doctor Negrín
2017

Madrid Health Service
2008

Hospital Universitario 12 De Octubre
2002-2007

Background: The most widely used validated instrument to assess the complexity of medication regimens is Medication Regimen Complexity Index (MRCI). Objective: This study aimed translate, adapt, and validate a reliable version MRCI adapted Spanish (MRCI-E). Methods: cross-cultural adaptation process consisted an independent translation by 3 clinical pharmacists backtranslation 2 native English speakers. A reliability analysis was conducted on 20 elderly randomly selected patients. Two...

10.1177/1060028016656385 article EN Annals of Pharmacotherapy 2016-07-03

Abstract Background Hereditary fructose intolerance (HFI) is a rare metabolic disease caused by aldolase B deficiency. The aim of our study was to analyse excipient tolerability in patients with HFI and other related diseases design mobile website health applications facilitate the search for drugs according their tolerance. Results A total 555 excipients listed Spanish Medicines Agency database (July 2023) were classified as suitable patients, considerations ((glucose glucose syrup,...

10.1186/s13023-023-03011-x article EN cc-by Orphanet Journal of Rare Diseases 2024-01-05

Describir el estudio ARPAS y analizar las características sociodemográficas, clínicas preferencias de los pacientes con tratamiento antirretroviral (TAR), así como la relación entre adherencia satisfacción TAR calidad vida. El ha evaluado a adultos, diagnosticados infección por VIH TAR, mediante un protocolo que incluye variables clínicas, terapéuticas La se estimó cuestionario SMAQ, ESTAR, vida MOS-HIV determinaron elaborado partir del consenso equipo experto en seguimiento terapéutico...

10.1016/s1130-6343(07)75406-5 article ES cc-by-nc-nd Farmacia Hospitalaria 2007-01-01

For the majority of cytotoxic drug preparations, such as bortezomib, unit dose information is not available. In addition, there a lack on physicochemical stability pharmaceutical preparation after opening; this crucial for its administration to patients in successive visits, and per-patient cost can be affected. The purpose our proposed study determine shelf life reconstituted liquid product under refrigeration clinical practice conditions. This evaluation was extended both vials...

10.1038/s41598-024-58473-1 article EN cc-by Scientific Reports 2024-04-18

Evaluar las características psicométricas, la validez convergente y fiabilidad de escala satisfacción con el tratamiento antirretroviral (ESTAR). La los pacientes TAR se determinó mediante ESTAR, desarrollada en castellano a partir version inglesa HIV-Treatment-Satisfaction-Questionnaire (HIVTSQ). Para su evaluación, midió consistencia interna test-retest. Se efectuó análisis constructo estudiando covarianza correlaciones cuestiones, valoró empleando como estándar cuestionario MOS-HIV...

10.1016/s1130-6343(07)75405-3 article ES cc-by-nc-nd Farmacia Hospitalaria 2007-01-01

In this article, we studied physicochemical and microbiological stability determined the beyond-use date of two oral solutions methadone in three storage conditions. For this, (10 mg/mL) were prepared, with without parabens, as preservatives. They packed amber glass vials kept unopened until day test, a multi-dose umber bottle opened daily. stored at 5 ± 3 °C, 25 2 °C 40 °C. pH, clarity, organoleptic characteristics obtained. A stability-indicating high-performance liquid chromatography...

10.3390/molecules27092812 article EN cc-by Molecules 2022-04-28

Abstract Purpose The Pharmacy Service of the Infanta Leonor University Hospital acquires, compounds, distributes and dispenses more than 3000 L methadone oral solution to Drug Addiction Patients Centers per year. Our purpose is develop validate an improved high performance liquid chromatography (HPLC) method quantify hydrochloride in a new with methylhydroxybenzoate (methylparaben) propylhydroxybenzoate (propylparaben) be implemented physicochemical stability studies that allow provide...

10.1186/s13065-022-00827-9 article EN cc-by BMC Chemistry 2022-05-14

The presence of HCV-RNA in saliva patients with chronic hepatitis C provides a biological basis for the potential transmission this virus. HCV viremia is particularly high HCV-HIV-coinfected patients, which could favor their saliva. This study was designed to evaluate prevalence patients. Stimulated whole collected from 75 and controls. tested by highly sensitive noncommercialized nested PCR, analyzed relation demographic, clinical, analytical variables. HCVRNA detected 49 (65%) 39 (52%) not...

10.1089/aid.2005.21.1011 article EN AIDS Research and Human Retroviruses 2005-12-01

Statements of the problem: Hepatitis C virus (HCV)‐RNA is often present in saliva HCV‐infected patients, with plasma viral load being only known predictable factor. Interferon plus ribavirin therapy yields a sustained reduction HCV viremia. This study aimed to assess presence and serum specimens from patients undergoing this combination (CT). Method study: Paired were collected 44 chronic at basal time, 4 12 weeks after CT onset, end treatment 6 months latter. Serum HCV‐RNA levels determined...

10.1111/j.1600-0714.2004.00290.x article EN Journal of Oral Pathology and Medicine 2005-03-30
Coming Soon ...